AbbVie (ABBV)
NYSE
ABBV: AbbVie last traded at $263.93 (+0.24%) on NYSE. Stock price, quote and news on TechGraph.
Current AbbVie forecasts and price targets
Analyst figures are shown only when the research feed provides them.
Scroll here to load data.
People also watch
Trending global stocks
Related in Drug Manufacturers—General
About AbbVie
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues. The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and…
Technical analysis
| Indicator | Call | Detail |
|---|---|---|
| Price vs SMA 20 | Sell | Last close is below the 20-session average. |
| Price vs SMA 50 | Sell | Medium-term trend is down. |
| SMA cross | Sell | The 20-session average is below the 50-session average. |
| RSI (14) | Neutral | RSI is in the mid-range. |
| MACD | Sell | MACD line is below zero. |
| Stochastic | Neutral | Stochastic is mid-range. |
Company profile
AbbVie executives and management
AbbVie financials and ownership
AbbVie revenue, operating income and earnings per share
Annual figures are charted only when the provider supplies comparable periods.
Scroll here to load data.
Key financial metrics
Financial Highlights
| Profit Margin | N/A |
| Operating Margin | N/A |
| Return on Assets | N/A |
| Return on Equity | N/A |
| Revenue | N/A |
| Quarterly Revenue Growth | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Cash Flow Statement
| Operating Cash Flow | N/A |
| Levered Free Cash Flow | N/A |
Share Statistics
| Avg Vol (3 month) | 7.08M |
| Shares Outstanding | 1.77B |
| Float | N/A |
| Short Ratio | N/A |
| Short % of Float | N/A |
Major Holders
| % of Shares Held by All Insiders | N/A |
| % of Shares Held by Institutions | N/A |
| % of Float Held by Institutions | N/A |
| Number of Institutions Holding Shares | N/A |
Financial statement fields will appear when the market-data feed provides usable fundamentals for this instrument.
AbbVie revenue by segment
Scroll here to load data.
AbbVie revenue by region
Scroll here to load data.
AbbVie stock margins
Scroll here to load data.
AbbVie historical valuation
Scroll here to load data.
AbbVie annual returns
Scroll here to load data.
AbbVie financial statements
Income statement, balance sheet and cash flow, with annual and quarterly periods.
Scroll here to load statements.
News & official updates
Related TechGraph coverage is not available for this instrument yet.
AbbVie fair value
Scroll here to load data.
AbbVie options chain
Scroll here to load data.
AbbVie — frequently asked questions
What is the price of AbbVie (ABBV) today?
AbbVie (ABBV) last traded at $263.93 (+0.24%) on NYSE, according to TechGraph market data.
Where is AbbVie listed?
AbbVie trades as ABBV on NYSE.
What is the 52-week range for ABBV?
The 52-week range for ABBV is $190.75 to $269.39.
What does AbbVie do?
AbbVie is a listed drug manufacturers—general company in the healthcare sector, traded on NYSE.
Price quotes refresh periodically while this page stays open; the chart follows the quote and refreshes exchange history less often. Some venues delay data by 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.